Paediatric schistosomiasis: What we know and what we need to know

Schistosomiasis affects over 200 million people worldwide, most of whom are children. Research and control strategies directed at preschool-aged children (PSAC), i.e., ≤5 years old, have lagged behind those in older children and adults. With the recent WHO revision of the schistosomiasis treatment guidelines to include PSAC, and the recognition of gaps in our current knowledge on the disease and its treatment in this age group, there is now a concerted effort to address these shortcomings. Global and national schistosome control strategies are yet to include PSAC in treatment schedules. Maximum impact of schistosome treatment programmes will be realised through effective treatment of PSAC. In this review, we (i) discuss the current knowledge on the dynamics and consequences of paediatric schistosomiasis and (ii) identify knowledge and policy gaps relevant to these areas and to the successful control of schistosome infection and disease in this age group. Herein, we highlight risk factors, immune mechanisms, pathology, and optimal timing for screening, diagnosis, and treatment of paediatric schistosomiasis. We also discuss the tools required for treating schistosomiasis in PSAC and strategies for accessing them for treatment.

• Publication year

  2018

• Venue

  PLoS Neglected Tropical Diseases

• Publication date

  2018-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1371/journal.pntd.0006144PMID 29420537PMCID 5805162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Practice

  2019cited by this paper
• Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial

  2017cited by this paper
• Putting the treatment of paediatric schistosomiasis into context

  2017cited by this paper
• Treatment of preschool children for schistosomiasis.

  2017cited by this paper
• Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial

  2017cited by this paper
• African Genetic Diversity: Implications for Cytochrome P450-mediated Drug Metabolism and Drug Development

  2017cited by this paper
• Innate lymphoid cells as regulators of immunity, inflammation and tissue homeostasis

  2016cited by this paper
• Nucleic acid detection in the diagnosis and prevention of schistosomiasis

  2016cited by this paper
• Expanding Praziquantel (PZQ) Access beyond Mass Drug Administration Programs: Paving a Way Forward for a Pediatric PZQ Formulation for Schistosomiasis

  2016cited by this paper
• Comparative Assessment of Health Benefits of Praziquantel Treatment of Urogenital Schistosomiasis in Preschool and Primary School-Aged Children

  2016cited by this paper
• Biomarkers of Environmental Enteropathy, Inflammation, Stunting, and Impaired Growth in Children in Northeast Brazil

  2016cited by this paper
• Prevalence and clinical correlates of Schistosoma mansoni co-infection among malaria infected patients, Northwest Ethiopia

  2015cited by this paper
• Group 2 Innate Lymphoid Cell Proportions Are Diminished in Young Helminth Infected Children and Restored by Curative Anti-helminthic Treatment

  2015cited by this paper
• A Review of Pharmacokinetic Drug–Drug Interactions with the Anthelmintic Medications Albendazole and Mebendazole

  2015cited by this paper
• CD4+CD25hiFOXP3+ Regulatory T Cells and Cytokine Responses in Human Schistosomiasis before and after Treatment with Praziquantel

  2015cited by this paper
• Effect of Antenatal Parasitic Infections on Anti-vaccine IgG Levels in Children: A Prospective Birth Cohort Study in Kenya

  2015cited by this paper
• The composition of the gut microbiota throughout life, with an emphasis on early life

  2015cited by this paper
• Chronic Trichuris muris Infection in C57BL/6 Mice Causes Significant Changes in Host Microbiota and Metabolome: Effects Reversed by Pathogen Clearance

  2015cited by this paper
• Identifying and Evaluating Field Indicators of Urogenital Schistosomiasis-Related Morbidity in Preschool-Aged Children

  2015influential reference
• Changing Policy and Practice in the Control of Pediatric Schistosomiasis

  2015cited by this paper
• Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children

  2015cited by this paper
• Comparing parasitological vs serological determination of Schistosoma haematobium infection prevalence in preschool and primary school-aged children: implications for control programmes

  2014cited by this paper
• The microbiota and helminths: sharing the same niche in the human host

  2014cited by this paper
• Schistosomiasis control: praziquantel forever?

  2014cited by this paper
• The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).

  2014cited by this paper
• Impact of Schistosoma mansoni on Malaria Transmission in Sub-Saharan Africa

  2014cited by this paper
• Urogenital schistosomiasis and urological assessment of hematuria in preschool-aged children in rural communities of Nigeria.

  2014cited by this paper
• Parasite-Derived MicroRNAs in Host Serum As Novel Biomarkers of Helminth Infection

  2014cited by this paper
• Deep sequencing-based identification of pathogen-specific microRNAs in the plasma of rabbits infected with Schistosoma japonicum

  2013cited by this paper
• Host serum miR-223 is a potential new biomarker for Schistosoma japonicum infection and the response to chemotherapy

  2013cited by this paper
• Prevalence and Associated Factors of Schistosomiasis among Children in Yemen: Implications for an Effective Control Programme

  2013cited by this paper
• Accuracy of Urine Circulating Cathodic Antigen Test for the Diagnosis of Schistosoma mansoni in Preschool-Aged Children before and after Treatment

  2013cited by this paper
• High-level colonisation of the human gut by Verrucomicrobia following broad-spectrum antibiotic treatment.

  2013cited by this paper
• Use of Cell-Free Circulating Schistosome DNA in Serum, Urine, Semen, and Saliva To Monitor a Case of Refractory Imported Schistosomiasis Hematobia

  2013cited by this paper
• Diagnosis of Schistosoma mansoni without the stool: comparison of three diagnostic tests to detect Schistosoma [corrected] mansoni infection from filtered urine in Zambia.

  2013cited by this paper
• Immunological Consequences of Antihelminthic Treatment in Preschool Children Exposed to Urogenital Schistosome Infection

  2013cited by this paper
• Impact of polyparasitic infections on anemia and undernutrition among Kenyan children living in a Schistosoma haematobium-endemic area.

  2013cited by this paper
• A Novel Mouse Model of Schistosoma haematobium Egg-Induced Immunopathology

  2012cited by this paper
• Chronic Schistosoma japonicum Infection Reduces Immune Response to Vaccine against Hepatitis B in Mice

  2012cited by this paper
• Treatment of schistosomiasis in African infants and preschool-aged children: downward extension and biometric optimization of the current praziquantel dose pole

  2012cited by this paper
• The role of nutrition in integrated programs to control neglected tropical diseases

  2012cited by this paper
• Protective immunity to Schistosoma haematobium infection is primarily an anti-fecundity response stimulated by the death of adult worms

  2012cited by this paper
• Validation of a New Test for Schistosoma haematobium Based on Detection of Dra1 DNA Fragments in Urine: Evaluation through Latent Class Analysis

  2012cited by this paper
• Gut Pharmacomicrobiomics: the tip of an iceberg of complex interactions between drugs and gut-associated microbes

  2012cited by this paper
• Use of Fecal Occult Blood Tests as Epidemiologic Indicators of Morbidity Associated with Intestinal Schistosomiasis during Preventive Chemotherapy in Young Children

  2012cited by this paper
• Integrated Analysis of Innate, Th1, Th2, Th17, and Regulatory Cytokines Identifies Changes in Immune Polarisation Following Treatment of Human Schistosomiasis

  2012cited by this paper
• Analysis of the Gut Microbiota in the Old Order Amish and Its Relation to the Metabolic Syndrome

  2012cited by this paper
• Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.

  2011cited by this paper
• Schistosoma haematobium Treatment in 1–5 Year Old Children: Safety and Efficacy of the Antihelminthic Drug Praziquantel

  2011cited by this paper
• Accuracy of circulating cathodic antigen tests for rapid mapping of Schistosoma mansoni and S. haematobium infections in Southern Sudan

  2011cited by this paper
• Regulatory and Activated T Cells in Human Schistosoma haematobium Infections

  2011cited by this paper
• A Multicentre Randomized Controlled Trial of the Efficacy and Safety of Single-Dose Praziquantel at 40 mg/kg vs. 60 mg/kg for Treating Intestinal Schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil

  2011cited by this paper
• Schistosoma haematobium infection affects Plasmodium falciparum‐specific IgG responses associated with protection against malaria

  2011cited by this paper
• Schistosoma-associated Salmonella resist antibiotics via specific fimbrial attachments to the flatworm

  2011cited by this paper
• Prevalence and risk factors of intestinal parasites among Delgi school children, North Gondar, Ethiopia

  2011cited by this paper
• Enterotypes of the human gut microbiome

  2011cited by this paper
• Integrated monitoring and evaluation and environmental risk factors for urogenital schistosomiasis and active trachoma in Burkina Faso before preventative chemotherapy using sentinel sites

  2011cited by this paper
• Intestinal Schistosomiasis in Mothers and Young Children in Uganda: Investigation of Field-Applicable Markers of Bowel Morbidity

  2010cited by this paper
• developing countries: lessons from a live cholera vaccine

  2010cited by this paper
• Induction of type 2 responses by schistosome worms during prepatent infection.

  2010cited by this paper
• Identification and differentiation of human schistosomes by polymerase chain reaction.

  2010cited by this paper
• Rapid induction of IgE responses to a worm cysteine protease during murine pre-patent schistosome infection

  2010cited by this paper
• Factors associated with urinary schistosomiasis in two peri-urban communities in south–western Nigeria

  2010cited by this paper
• Increases in levels of schistosome-specific immunoglobulin E and CD23(+) B cells in a cohort of Kenyan children undergoing repeated treatment and reinfection with Schistosoma mansoni.

  2010cited by this paper
• Schistosomiasis in infants and preschool-aged children: Infection in a single Schistosoma haematobium and a mixed S. haematobium-S. mansoni foci of Niger.

  2010cited by this paper
• Treatment of intestinal schistosomiasis in Ugandan preschool children: best diagnosis, treatment efficacy and side-effects, and an extended praziquantel dosing pole

  2010cited by this paper
• Evaluation of polymerase chain reaction as an additional tool for the diagnosis of low-intensity Schistosoma mansoni infection.

  2010cited by this paper
• An inclusive dose pole for treatment of schistosomiasis in infants and preschool children with praziquantel.

  2010cited by this paper
• Protection against a malaria challenge by sporozoite inoculation.

  2009cited by this paper
• Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

  2009cited by this paper
• Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model.

  2009cited by this paper
• A multi-level analysis of risk factors for Schistosoma japonicum infection in China.

  2009cited by this paper
• Prevalence Distribution and Risk Factors for Schistosoma hematobium Infection among School Children in Blantyre, Malawi

  2009cited by this paper
• Age-related and infection intensity-related shifts in antibody recognition of defined protein antigens in a schistosome-exposed population.

  2008cited by this paper
• Micro-epidemiology of urinary schistosomiasis in Zanzibar: Local risk factors associated with distribution of infections among schoolchildren and relevance for control.

  2008cited by this paper
• Recent progress in integrated neglected tropical disease control.

  2007cited by this paper
• Comparison of the Kato-Katz technique, hatching test and indirect hemagglutination assay (IHA) for the diagnosis of Schistosoma japonicum infection in China.

  2007cited by this paper
• Chronic helminth infections induce immunomodulation: consequences and mechanisms.

  2007cited by this paper
• Imported Katayama fever: clinical and biological features at presentation and during treatment.

  2006cited by this paper
• Schistosoma japonicum Reinfection after Praziquantel Treatment Causes Anemia Associated with Inflammation

  2006cited by this paper
• Human schistosomiasis.

  2006cited by this paper
• Schistosoma mansoni in infants (aged <3 years) along the Ugandan shoreline of Lake Victoria

  2006cited by this paper
• Praziquantel treatment of individuals exposed to Schistosoma haematobium enhances serological recognition of defined parasite antigens.

  2005cited by this paper
• Efficacy of an enzyme-linked immunosorbent assay as a diagnostic tool for schistosomiasis mansoni in individuals with low worm burden.

  2005cited by this paper
• Prevention and control of schistosomiasis and soil-transmitted helminthiasis

  2004cited by this paper
• Comparison of a polymerase chain reaction and the Kato-Katz technique for diagnosing infection with Schistosoma mansoni.

  2003cited by this paper
• Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa.

  2003cited by this paper
• Soil-transmitted helminth infections: updating the global picture.

  2003cited by this paper
• Identification of human cytochrome P450s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data

  2003cited by this paper
• Albendazole, mebendazole and praziquantel. Review of non-clinical toxicity and pharmacokinetics.

  2003cited by this paper
• Estimating the burden of disease from water, sanitation, and hygiene at a global level

  2002cited by this paper
• Estimating the burden of disease from water, sanitation, and hygiene at a global level.

  2002cited by this paper
• Prevention and control of schistosomiasis and soil-transmitted helminthiasis.

  2002cited by this paper
• Exposure, infection and immune responses to Schistosoma haematobium in young children

  2000cited by this paper
• Alternatives to bodyweight for estimating the dose of praziquantel needed to treat schistosomiasis.

  1999cited by this paper
• A comparative epidemiologic study of specific antibodies (IgM and IgA) and parasitological findings in an endemic area of low transmission of schistosoma mansoni.

  1998cited by this paper
• Chemotherapy accelerates the development of acquired immune responses to Schistosoma haematobium infection.

  1998cited by this paper
• In utero exposure to helminth and mycobacterial antigens generates cytokine responses similar to that observed in adults.

  1997cited by this paper
• A comparison of humoral responses to Schistosoma haematobium in areas with low and high levels of infection

  1997cited by this paper
• Validation of a chart to estimate true Schistosoma mansoni prevalences from simple egg counts

  1997cited by this paper

• Association between Schistosoma mansoni infection and fecal occult blood in schoolchildren in Mbita, Suba North sub-county, western Kenya

  2026cites this paper
• Identifying gaps in the care and management of NTD morbidity, disability and disfigurement in Africa

  2025cites this paper
• Co-infections of Schistosoma mansoni and Helicobacter pylori in school-aged populations and implication for management and control practices in Niger State, Nigeria

  2025cites this paper
• Effect of behavioral interventions on schistosomiasis-related knowledge, attitudes, and practices of schoolchildren in Pemba, Tanzania: A 4-year repeated cross-sectional study

  2025cites this paper
• Identifying hotspots of S. haematobium infection following praziquantel treatment during multiple annual mass drug administration campaigns in Zimbabwe

  2025cites this paper
• Prevalence, intensity, and associated factors of soil-transmitted helminth and schistosome infections after multiple rounds of preventive chemotherapy among schoolchildren in five selected district councils in Tanzania

  2025cites this paper
• Schistosoma haematobium infection and associated risk factors among pre-school age children in Gambella, Ethiopia

  2025cites this paper
• Microsampling with dried blood spots and mass spectrometry enables PK/PD profiling of responses to praziquantel in a Schistosoma haematobium-exposed Zimbabwean population.

  2025cites this paper
• An Unusual Case of Mesenteric Schistosomiasis Presenting as Bowel Obstruction in a Child

  2025cites this paper
• Pre-school Age Participation in Mass Drug Administration: Analysing the Impact on Community-wide Schistosomiasis Control

  2025cites this paper
• Case report of rare presentation of schistosomiasis: delayed diagnosis of genitourinary schistosomiasis in an adolescent.

  2025cites this paper
• Pediatric epididymal schistosomiasis, challenging diagnosis, and implications

  2025cites this paper
• Schistosome Transgenesis: The Long Road to Success

  2024cites this paper
• Contextual factors influencing schistosomiasis treatment and identification of delivery platforms for arpraziquantel in hard-to-reach areas and populations in Homa Bay County, Kenya

  2024cites this paper
• Schistosomiasis in migrant children and adolescents in a paediatric tropical referral unit in Spain: diagnosis and long-term management challenges

  2024cites this paper
• Assessment of urine metabolite biomarkers for the detection of S. haematobium infection in pre-school aged children in a rural community in Zimbabwe.

  2024cites this paper
• Paediatric schistosomiasis: last mile preparations for deploying paediatric praziquantel.

  2024cites this paper
• Diagnosis of Human Trematode Infections.

  2024cites this paper
• Effects of paediatric schistosomiasis control programmes in sub-Saharan Africa: A systematic review

  2024cites this paper
• Threshold dynamics of a reaction–advection–diffusion schistosomiasis epidemic model with seasonality and spatial heterogeneity

  2024cites this paper
• Plasma metabolite profiling for S. haematobium biomarkers of infection in pre-school aged children in Shamva District, Zimbabwe

  2024cites this paper
• Where will pediatric praziquantel be needed in Tanzania? Geographical variation in prevalence, and risk factors of Schistosoma mansoni in pre-school aged children in southern and north-western Tanzania

  2024cites this paper
• Pediatric urogenital schistosomiasis diagnosed in France

  2024cites this paper
• CRISPR-assisted test for Schistosoma haematobium

  2023cites this paper
• Schistosoma japonicum Associated Colorectal Cancer and Its Management

  2023cites this paper
• Assessing the knowledge, attitudes, practices, and perspectives of stakeholders of the deworming program in rural Rwanda

  2023cites this paper
• Prevalence and Determinants of Schistosoma mansoni Infection among Pre-School Age Children in Southern Ethiopia

  2023cites this paper
• Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: a scoping review

  2023influential citation
• Metabolomics for biomarker discovery in schistosomiasis: A systematic scoping review

  2023cites this paper
• Teachers as multipliers of knowledge about schistosomiasis: a possible approach for health education programmes

  2022cites this paper
• Improving anthelmintic treatment for schistosomiasis and soil-transmitted helminthiases through sharing and reuse of individual participant data

  2022cites this paper
• Open defecation: risk factors for adverse outcomes in Indonesia

  2022cites this paper
• Schistosomiasis outbreak during COVID-19 pandemic in Takum, Northeast Nigeria: Analysis of infection status and associated risk factors

  2022cites this paper
• Persistence of Schistosoma haematobium transmission among school children and its implication for the control of urogenital schistosomiasis in Lindi, Tanzania

  2022cites this paper
• Chronic Urogenital Schistosomiasis among In-School Adolescents in Sokoto, North-Western Nigeria

  2022cites this paper
• Screening for parasites in migrant children.

  2022cites this paper
• Prevalence and risk factors of urogenital schistosomiasis among under-fives in Mtama District in the Lindi region of Tanzania

  2022influential citation
• Prevalence Mapping of Schistosoma mansoni Among Pre-school Age Children in Rwanda

  2022cites this paper
• Development of the Sm14/GLA-SE Schistosomiasis Vaccine Candidate: An Open, Non-Placebo-Controlled, Standardized-Dose Immunization Phase Ib Clinical Trial Targeting Healthy Young Women

  2022cites this paper
• Patient journey and resources mapping to implement a praziquantel mass drug administration program for children aged 5 years and below in resource-limited settings

  2022cites this paper
• Epidemiology of pediatric schistosomiasis in hard-to-reach areas and populations: A scoping review protocol

  2022cites this paper
• Effect of Schistosoma haematobium infection on the cognitive functions of preschool age children and benefits of treatment from an endemic area in Zimbabwe

  2022cites this paper
• Intestinal schistosomiasis among secondary school students in Northern Tanzania: prevalence, infection intensity and associated risk factors

  2022cites this paper
• A Proposed Framework for Early Prediction of Schistosomiasis

  2022cites this paper
• Development of the Sm14/GLA-SE - schistosomiasis vaccine candidate: An open, not placebo-controlled, standardized dose immunization phase Ib clinical trial targeting healthy young women

  2022cites this paper
• Effects of TNF-α and IL-10-819 T>C single nucleotide polymorphisms on urogenital schistosomiasis in preschool children in Zimbabwe

  2021cites this paper
• Polarization of intestinal tumour-associated macrophages regulates the development of schistosomal colorectal cancer

  2021cites this paper
• Prevalence, infection intensity and geographical distribution of schistosomiasis among pre-school and school aged children in villages surrounding Lake Nyasa, Tanzania

  2021cites this paper
• Direct Powder Extrusion 3D Printing of Praziquantel to Overcome Neglected Disease Formulation Challenges in Paediatric Populations

  2021cites this paper
• Algorithm for diagnosis of early Schistosoma haematobium using prodromal signs and symptoms in pre-school age children in an endemic district in Zimbabwe

  2021cites this paper
• Prevalence of intestinal schistosomiasis in pre-school aged children: a pilot survey in Marolambo District, Madagascar

  2021cites this paper
• Medullary neuroschistosomiasis in a pediatric patient: a case report

  2021cites this paper
• Efficacy and Safety of New Orodispersible Tablet Formulations of Praziquantel (Racemate and L-Praziquantel) in Schistosoma mansoni-Infected Preschool-Age Children and Infants: A Randomized Dose-Finding Phase 2 Study

  2021cites this paper
• Comparison of POC-CCA with Kato-Katz in Diagnosing Schistosoma mansoni Infection in a Pediatric L-Praziquantel Clinical Trial

  2021cites this paper
• Haematuria in children.

  2021cites this paper
• Gender Related Differences in Infection Intensity, Prevalence and Risk of Schistosoma Mansoni and Schistosoma Haematobium: A Systematic Review Protocol

  2020cites this paper
• Edinburgh Research Explorer Efficacy and safety of single 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children

  2020cites this paper
• RRTM_A_274518 119..128

  2020cites this paper
• Edinburgh Research Explorer Efficacy and safety of single 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children

  2020cites this paper
• Current Understanding of Immunity Against Schistosomiasis: Impact on Vaccine and Drug Development

  2020cites this paper
• Association of Schistosoma haematobium infection morbidity and severity on co-infections in pre-school age children living in a rural endemic area in Zimbabwe

  2020cites this paper
• Investigating a strategy for quantifying schistosome infection levels in preschool-aged children using prevalence data from school-aged children

  2020cites this paper
• Unveiling the potential of purinergic signaling in schistosomiasis treatment.

  2020cites this paper
• Single oral fixed-dose praziquantel-miltefosine nanocombination for effective control of experimental schistosomiasis mansoni

  2020cites this paper
• Prevalence and risk factors of Schistosoma mansoni infection among children under two years of age in Mbita, Western Kenya

  2020cites this paper
• Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis

  2020cites this paper
• Clinical morbidity associated with Schistosoma haematobium infection in pre‐school age children from an endemic district in Zimbabwe

  2020influential citation
• Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate schistosomiasis.

  2020cites this paper
• 1 Sensitive diagnostic tools and targeted drug administration strategies are needed to eliminate 1 schistosomiasis 2 3

  2020cites this paper
• Association of S. haematobium Infection Morbidity and Severity on Co-infections status in Pre-school Age Children Living in a Rural Endemic  Area in Zimbabwe

  2020cites this paper
• Schistosomiasis Control: Leave No Age Group Behind.

  2020cites this paper
• Parasite Population Genetic Contributions to the Schistosomiasis Consortium for Operational Research and Evaluation within Sub-Saharan Africa

  2020cites this paper
• The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children

  2020cites this paper
• Mapping the Process and the Resources That Are Needed to Implement a Praziquantel Mass Drug Administration Program for Children Aged Five Years Old and Below in Resource Limited Settings: a Scoping Review

  2020influential citation
• Fighting COVID-19 in Freetown, Sierra Leone: the critical role of community organisations in a growing pandemic

  2020influential citation
• A systematic review and meta-analysis quantifying schistosomiasis infection burden in pre-school aged children (PreSAC) in sub-Saharan Africa for the period 2000–2020

  2020cites this paper
• The potential impact of including pre-school aged children in the praziquantel mass-drug administration programmes on the S.haematobium infections in Malawi: a modelling study

  2020cites this paper
• Perspective Piece Restaging Pulmonary Schistosomiasis

  2019cites this paper
• Anti-parasitic activity of polyether ionophores.

  2019cites this paper
• A prospective risk assessment of the implementation of a schistosomiasis preventive mass drug administration for children aged five years and below in the uMkhanyakude district of KwaZulu-Natal

  2019cites this paper
• Factors associated with relevant knowledge of intestinal schistosomiasis and intention to participate in treatment campaigns: a cross sectional survey among school children at Ijinga Island on Lake Victoria, North-Western Tanzania

  2019cites this paper
• The Liver in Systemic Illness

  2019cites this paper
• Diagnosis of Human Trematode Infections.

  2019cites this paper
• Extracellular vesicles in parasite survival

  2019cites this paper
• Restaging Pulmonary Schistosomiasis.

  2019cites this paper
• Intestinal schistosomiasis of Ijinga Island, north-western Tanzania: prevalence, intensity of infection, hepatosplenic morbidities and their associated factors

  2019cites this paper
• A prospective risk assessment of the implementation of a Schistosomiasis Preventive Mass Drug Administration for children aged below five years in the uMkhanyakude District of KwaZulu-Natal

  2019cites this paper
• Pediatric Hepatology and Liver Transplantation

  2019cites this paper
• Comparative palatability of orally disintegrating tablets (ODTs) of Praziquantel (L-PZQ and Rac-PZQ) versus current PZQ tablet in African children: A randomized, single-blind, crossover study

  2019cites this paper
• Coalescing beneficial host and deleterious antiparasitic actions as an antischistosomal strategy

  2018cites this paper
• Current Status of the Sm14/GLA-SE Schistosomiasis Vaccine: Overcoming Barriers and Paradigms towards the First Anti-Parasitic Human(itarian) Vaccine

  2018cites this paper
• Publications by Edinburgh Infectious Diseases Members in 2018

  year unknowncites this paper